FGF23 and chronic kidney disease: Current literature supports such a thesis, and has indicated that the development and progression of CKD is significantly associated with a dysregulated FGF23-Klotho pathway, resulting in hyperphosphatemia and endothelial dysfunction (8, 18, 53–55).